| 1 |
time to castration resistance
(7 times)
|
Neoplasms
(4 times)
|
mCRPC (4 times)
PSA (4 times)
OS (3 times)
|
2019 The Effect of Time to Castration Resistance on Overall Survival and Success of Docetaxel Treatment in Castration Resistant Prostate Cancer Patients.
|
| 2 |
time to clinical recovery
(2 times)
|
Complementary Therapies
(1 time)
|
COVID-19 (1 time)
CT (1 time)
CTRI (1 time)
|
2020 Safety and efficacy of antiviral combination therapy in symptomatic patients of Covid-19 infection - a randomised controlled trial (SEV-COVID Trial): A structured summary of a study protocol for a randomized controlled trial.
|
| 3 |
true three-dimensional cone-beam reconstruction
(2 times)
|
Diagnostic Imaging
(1 time)
|
TTR (1 time)
|
1989 True three-dimensional cone-beam reconstruction (TTCR) algorithm.
|
| 4 |
time to chemorefractoriness
(1 time)
|
Hematology
(1 time)
|
BM (1 time)
CE (1 time)
CLL (1 time)
|
2011 Clonal evolution including 14q32/IGH translocations in chronic lymphocytic leukemia: analysis of clinicobiologic correlations in 105 patients.
|
| 5 |
time to chemotherapy resistance
(1 time)
|
Prostatic Neoplasms
(1 time)
|
CI (1 time)
GM-CSF (1 time)
mCRPC (1 time)
|
2015 Intermittent Chemotherapy as a Platform for Testing Novel Agents in Patients With Metastatic Castration-Resistant Prostate Cancer: A Department of Defense Prostate Cancer Clinical Trials Consortium Randomized Phase II Trial of Intermittent Docetaxel With Prednisone With or Without Maintenance GM-CSF.
|
| 6 |
time to clinical recommendation
(1 time)
|
|
COPD (1 time)
IQR (1 time)
PCPs (1 time)
|
2021 Use of a Digital Chronic Obstructive Pulmonary Disease Respiratory Tracker in a Primary Care Setting: A Feasibility Study.
|
| 7 |
time to clinical resolution
(1 time)
|
Therapeutics
(1 time)
|
AEs (1 time)
ICU (1 time)
NAI (1 time)
|
2020 Alternative Regimens of Neuraminidase Inhibitors for Therapy of Hospitalized Adults with Influenza: A Systematic Review of Randomized Controlled Trials.
|
| 8 |
time to clinical response
(1 time)
|
Communicable Diseases
(1 time)
|
AEs (1 time)
|
2019 Efficacy and Safety of Danirixin (GSK1325756) Co-administered With Standard-of-Care Antiviral (Oseltamivir): A Phase 2b, Global, Randomized Study of Adults Hospitalized With Influenza.
|
| 9 |
time to complete resolution of wheals
(1 time)
|
Biology
(1 time)
|
COX (1 time)
eNOS (1 time)
ID (1 time)
|
2019 Cyclooxygenase activity in bradykinin-induced dermal extravasation. A study in mice and humans.
|
| 10 |
time-to-complete remission
(1 time)
|
Neoplasms
(1 time)
|
BCLC (1 time)
CHC (1 time)
DAA (1 time)
|
2021 Direct-acting Antiviral Therapy Improves the Outcome of Chronic Hepatitis C/intermediate-stage B Hepatocellular Carcinoma Patients.
|
A Search Service for Abbreviation / Long Form